Ryan F. Quarles: “The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.”

I think that you can actually have more effect in really supporting the low- and moderate-income portions of the communities.

That is probably the highest priority item that we have, discussing ways to ensure that our systems are resilient.

The Federal Reserve, along with the other U.S. banking agencies, has made substantial progress in building stronger regulatory and supervisory programs since the global financial crisis.

Kentucky's legislative and regulatory framework is widely recognized today as one of the best in the nation.